New research explored tumour heterogeneity - where different cells have different appearances or their own DNA signatures within the same cancer. The research got published in the journal iOncotarget/i. Such differences could make it difficult to design effective, targeted treatment strategies. Firstly they confirmed the mutual exclusivity between the EGFR mutation and either the KRAS or BRAF mutation. Secondly, they found that lung cancers driven ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/QIPnRS
No comments:
Post a Comment